Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
KKAKEN PHARMACEUTICAL CO.,LTD. logo
4521TSE Prime

KAKEN PHARMACEUTICAL CO.,LTD.

科研製薬 Yahoo Finance

Recent & upcoming events

Aug 7
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 25
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 13
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 30
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 29
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 23
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 16
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥76.87B YoY -18.3%
Operating income ¥-899M margin -1.2%
Net income ¥2.14B YoY -84.6%
EPS ¥57 YoY -84.5%
P/E —
ROE 1.4% Equity ratio 83% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥89.90B +16.9%
Operating income ¥7.90B —
Net income ¥6.50B +203.2%
EPS ¥172 +203.4%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q2
Revenue ¥18.15B¥18.02B¥18.51B¥17.36B——
Operating income ¥3.29B¥2.22B¥3.36B¥641M——
Net income ¥2.51B¥1.56B¥2.61B¥1.35B——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 5.3%国内機関 24.6%海外機関 4.8%個人 6.4%未開示 59%202120222023202420252026
事業法人国内機関海外機関アクティビスト個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本マスタートラスト信託銀行株式会社 10.2%日本マスタートラスト信託銀行株式会社(信託口)株式会社日本カストディ銀行(信託口) 5.7%株式会社日本カストディ銀行(信託口)農林中央金庫 4.8%農林中央金庫ゴールドマン・サックス・アンド・カン 4.8%ゴールドマン・サックス・アンド・カンパニーレギュラーアカウント (常任代理人　ゴールドマン・サックス証券株式会社)株式会社みずほ銀行 3.9%株式会社みずほ銀行東レ株式会社 3%東レ株式会社ステート　ストリート　バンク　アンド 2.5%ステート　ストリート　バンク　アンド　トラスト　カンパニー　505103(常任代理人　株式会社みずほ銀行決済営業部)ステート　ストリート　バンク　アンド 2.3%ステート　ストリート　バンク　アンド　トラスト　カンパニー　505001(常任代理人　株式会社みずほ銀行決済営業部)杏林製薬株式会社 2.2%杏林製薬株式会社科研製薬従業員持株会 1.6%科研製薬従業員持株会202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
日本マスタートラスト信託銀行株式会社(信託口) 3,891,000 10.2% Yuho (EDINET)
株式会社日本カストディ銀行(信託口) 2,170,000 5.7% Yuho (EDINET)
農林中央金庫 1,843,000 4.8% Yuho (EDINET)
ゴールドマン・サックス・アンド・カンパニーレギュラーアカウント 1,809,000 4.8% Yuho (EDINET)
株式会社みずほ銀行 1,474,000 3.9% Yuho (EDINET)
東レ株式会社 1,147,000 3.0% Yuho (EDINET)
ステート ストリート バンク アンド トラスト カンパニー 505103 955,000 2.5% Yuho (EDINET)
ステート ストリート バンク アンド トラスト カンパニー 505001 864,000 2.3% Yuho (EDINET)
杏林製薬株式会社 852,000 2.2% Yuho (EDINET)
科研製薬従業員持株会 608,000 1.6% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

4/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 1.2%
✗ Positive operating cash flow ¥-11.08B
✗ ROA improved YoY 7.3% → 1.2%
✗ Operating CF exceeds net income (accrual quality) OCF ¥-11.08B / net income ¥2.14B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 80.2% → 82.8%
✓ Current ratio improved 3.67× → 4.52×
✓ No dilution (shares outstanding did not increase) 45,939,000 → 44,139,000
✗ Gross margin improved 62.2% → 52.0%
✗ Asset turnover improved 0.49× → 0.43×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 82.8%
Current ratio 4.5×
Years of positive operating CF 9 of last 10 yrs
Payout ratio 367%
Latest fiscal year result Profit (net income ¥2.14B)

Performance history

Last 10 years
0億円254億円507億円761億円1,015億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 1,015984942892750760730720940769
Operating income 30727524626517817180.095.1210-8.99
Ordinary income 31027925026918217587.399.5213-2.06
Net income 22019017819413495.554.480.313921.4
Total assets 1,3511,5241,5601,5791,6331,6521,6631,7161,9041,782
Equity 1,0271,1391,2111,2851,3631,3831,3681,4381,5261,476

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥537¥471¥446¥495¥347¥251¥145¥213¥365¥57
ROE 22.9%17.6%15.1%15.5%10.1%7.0%4.0%5.7%9.4%1.4%
Operating CF 15321721127514413392.525.8298-111
Investing CF -35.0-32.5-57.4-25.3-16.4-78.9-26.3-58.5-1973.15
Financing CF -98.0-95.3-95.2-102-87.5-81.3-69.9-56.6-53.7-88.4
FCF 11818515424912754.566.3-32.8101-108

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data